CRM(SH:688396)2022-10-26 16:00Financial Performance - The operating revenue for Q3 2022 was CNY 2,485,960,150.57, representing a year-on-year increase of 0.54%[4] - The net profit attributable to shareholders was CNY 703,145,353.73, reflecting a year-on-year growth of 14.14%[4] - The net profit excluding non-recurring gains and losses was CNY 555,961,583.45, with a year-on-year increase of 3.20%[4] - Total operating revenue for the first three quarters of 2022 reached ¥7,631,706,678.53, an increase of 10.2% compared to ¥6,927,507,593.54 in the same period of 2021[15] - Net profit for the third quarter of 2022 was ¥2,037,871,527.90, a significant increase from ¥1,675,190,177.71 in the third quarter of 2021, representing a growth of 21.6%[16] - Basic earnings per share for the period were CNY 0.5326, an increase of 14.12% compared to the same period last year[5] - Basic earnings per share for the third quarter of 2022 were ¥1.5583, compared to ¥1.3218 in the same quarter of 2021, indicating an increase of 17.9%[17] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 25,245,130,126.51, up 13.76% from the end of the previous year[5] - Current assets totaled RMB 16,662,442,472.49, up from RMB 14,691,591,066.27, indicating a year-over-year increase of about 13.4%[12] - The company's cash and cash equivalents amounted to RMB 12,674,595,337.34, compared to RMB 11,246,199,567.83 in the previous year, reflecting a growth of approximately 12.7%[11] - Total liabilities amounted to RMB 4,957,449,424.86, slightly up from RMB 4,690,796,944.11, indicating a growth of approximately 5.7%[13] - The total equity of the company reached RMB 20,287,680,701.65, up from RMB 17,500,412,620.22, indicating a growth of approximately 15.3%[14] Research and Development - R&D investment totaled CNY 235,288,550.52, accounting for 9.46% of operating revenue, an increase of 0.57 percentage points compared to the previous year[5] - Research and development expenses increased to ¥619,656,736.93 in the first three quarters of 2022, compared to ¥502,848,335.00 in the same period of 2021, marking a rise of 23.2%[15] Cash Flow - The company reported a net cash flow from operating activities of CNY 2,375,653,073.57 for the year-to-date, a decrease of 3.87% year-on-year[5] - Cash inflows from operating activities totaled CNY 7,642,111,863.82, compared to CNY 7,006,973,758.83 in the previous year, reflecting an increase of approximately 9%[38] - The cash flow from operating activities for the first three quarters of 2022 was ¥2,375,653,073.57, slightly down from ¥2,471,164,174.09 in the same period of 2021[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 62,917[8] - The largest shareholder, China Resources (Microelectronics) Co., Ltd., held 66.58% of the shares[8] - The company has a significant shareholder structure, with China Resources Microelectronics holding 66.58% of the shares, indicating strong institutional support[28] Overall Financial Health - The weighted average return on equity was 3.6936%, a decrease of 0.07 percentage points year-on-year[5] - The company reported a significant increase in other receivables, which rose to RMB 25,000,554.22 from RMB 15,039,512.94, a growth of about 66.3%[12] - The company is actively monitoring its financial health and operational strategies to ensure continued growth and market competitiveness[30] - The company has maintained a stable financial position with no reported changes in the status of major shareholders, indicating a stable governance structure[29]